| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ABHD12 | ABHD6 | ENSOARP00000008099 | ENSOARP00000013369 | Abhydrolase domain containing 12. | Abhydrolase domain containing 6. | 0.930 |
| ABHD12 | FAAH | ENSOARP00000008099 | ENSOARP00000002616 | Abhydrolase domain containing 12. | Fatty acid amide hydrolase. | 0.738 |
| ABHD12 | LOC101103602 | ENSOARP00000008099 | ENSOARP00000002644 | Abhydrolase domain containing 12. | Amidase domain-containing protein. | 0.695 |
| ABHD12 | NAPEPLD | ENSOARP00000008099 | ENSOARP00000020330 | Abhydrolase domain containing 12. | N-acyl phosphatidylethanolamine phospholipase D. | 0.689 |
| ABHD6 | ABHD12 | ENSOARP00000013369 | ENSOARP00000008099 | Abhydrolase domain containing 6. | Abhydrolase domain containing 12. | 0.930 |
| ABHD6 | FAAH | ENSOARP00000013369 | ENSOARP00000002616 | Abhydrolase domain containing 6. | Fatty acid amide hydrolase. | 0.873 |
| ABHD6 | GPR55 | ENSOARP00000013369 | ENSOARP00000021274 | Abhydrolase domain containing 6. | G protein-coupled receptor 55; Belongs to the G-protein coupled receptor 1 family. | 0.454 |
| ABHD6 | LOC101103602 | ENSOARP00000013369 | ENSOARP00000002644 | Abhydrolase domain containing 6. | Amidase domain-containing protein. | 0.873 |
| ABHD6 | NAPEPLD | ENSOARP00000013369 | ENSOARP00000020330 | Abhydrolase domain containing 6. | N-acyl phosphatidylethanolamine phospholipase D. | 0.898 |
| CNR1 | FAAH | ENSOARP00000021470 | ENSOARP00000002616 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Fatty acid amide hydrolase. | 0.745 |
| CNR1 | GPR55 | ENSOARP00000021470 | ENSOARP00000021274 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | G protein-coupled receptor 55; Belongs to the G-protein coupled receptor 1 family. | 0.722 |
| CNR1 | LOC101103602 | ENSOARP00000021470 | ENSOARP00000002644 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Amidase domain-containing protein. | 0.746 |
| CNR1 | NAPEPLD | ENSOARP00000021470 | ENSOARP00000020330 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | N-acyl phosphatidylethanolamine phospholipase D. | 0.628 |
| CNR1 | TRPV1 | ENSOARP00000021470 | ENSOARP00000018383 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Transient receptor potential cation channel subfamily V member 1. | 0.543 |
| DARS2 | EPRS1 | ENSOARP00000013552 | ENSOARP00000012685 | Aspartyl-tRNA synthetase 2, mitochondrial. | Glutamyl-prolyl-tRNA synthetase. | 0.969 |
| DARS2 | FAAH | ENSOARP00000013552 | ENSOARP00000002616 | Aspartyl-tRNA synthetase 2, mitochondrial. | Fatty acid amide hydrolase. | 0.859 |
| DARS2 | GATB | ENSOARP00000013552 | ENSOARP00000004665 | Aspartyl-tRNA synthetase 2, mitochondrial. | Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial; Allows the formation of correctly charged Gln-tRNA(Gln) through the transamidation of misacylated Glu-tRNA(Gln) in the mitochondria. The reaction takes place in the presence of glutamine and ATP through an activated gamma-phospho-Glu-tRNA(Gln). Belongs to the GatB/GatE family. GatB subfamily. | 0.998 |
| DARS2 | LOC101103602 | ENSOARP00000013552 | ENSOARP00000002644 | Aspartyl-tRNA synthetase 2, mitochondrial. | Amidase domain-containing protein. | 0.859 |
| EPRS1 | DARS2 | ENSOARP00000012685 | ENSOARP00000013552 | Glutamyl-prolyl-tRNA synthetase. | Aspartyl-tRNA synthetase 2, mitochondrial. | 0.969 |
| EPRS1 | FAAH | ENSOARP00000012685 | ENSOARP00000002616 | Glutamyl-prolyl-tRNA synthetase. | Fatty acid amide hydrolase. | 0.963 |